Generate Biomedicines
GENB
#5241
Rank
โ‚ฌ1.50 B
Marketcap
11,75ย โ‚ฌ
Share price
-3.11%
Change (1 day)
N/A
Change (1 year)

Revenue for Generate Biomedicines (GENB)

Revenue in 2026 (TTM): โ‚ฌ14.39 Million

According to Generate Biomedicines's latest financial reports the company's current revenue (TTM ) is โ‚ฌ27.97 Million. In 2025 the company made a revenue of โ‚ฌ27.97 Million an increase over the revenue in the year 2024 that were of โ‚ฌ17.94 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Generate Biomedicines from 2024 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ14.39 M-48.55%
2025 โ‚ฌ27.97 M55.89%
2024โ‚ฌ17.94 M